Jose C Appolinario, Maria Angélica A Nunes, Carla Mourilhe, Angelica Claudino, Bacy Fleitlich-Bilyk, Marle Alvarenga, Silvia Regina Freitas, João C Hiluy, Maria Francisca F P Mauro, Maria Eliza G Cury, Pamela Gouveia, Maria Amalia Pedrosa, Adriano Segal, Taki A Cordas, Mireille Almeida, Antonio Geraldo da Silva, Leonardo Baldaçara
{"title":"Brazilian Psychiatric Association guidelines for the treatment of eating disorders.","authors":"Jose C Appolinario, Maria Angélica A Nunes, Carla Mourilhe, Angelica Claudino, Bacy Fleitlich-Bilyk, Marle Alvarenga, Silvia Regina Freitas, João C Hiluy, Maria Francisca F P Mauro, Maria Eliza G Cury, Pamela Gouveia, Maria Amalia Pedrosa, Adriano Segal, Taki A Cordas, Mireille Almeida, Antonio Geraldo da Silva, Leonardo Baldaçara","doi":"10.47626/1516-4446-2026-5102","DOIUrl":null,"url":null,"abstract":"<p><p>Eating disorders (ED), such as anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED), are serious psychiatric conditions that significantly impact psychological and medical health. This paper aims to summarize the recommendations of the Brazilian Association of Psychiatry - [Associação Brasileira de Psiquiatria (ABP)] for the treatment of EDs, based on the latest available evidence. Systematic reviews focused on the multidisciplinary treatment of ED were conducted. Findings were evaluated based on evidence strength, and recommendations using the evidence-based methodology of the Oxford Centre for Evidence-Based Medicine, finalized by an expert panel consensus. A summary of the recommendations and their corresponding levels of evidence was produced. Overall, the management of AN should use the least restrictive setting, combining monitored nutritional rehabilitation with psychotherapy. Pharmacotherapy plays a limited role in selected cases. BN is typically managed in an outpatient setting, focusing on structured nutritional care and CBT-based treatment, with pharmacotherapy adjunctive, preferably fluoxetine. BED is treated in an outpatient setting with structured care and CBT, with lisdexamfetamine as the preferred pharmacotherapy when needed. These guidelines represent a significant advancement in managing eating disorders in Brazil, providing a structured framework for clinical care while also supporting the development of future public mental health policies.</p>","PeriodicalId":520767,"journal":{"name":"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47626/1516-4446-2026-5102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Eating disorders (ED), such as anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED), are serious psychiatric conditions that significantly impact psychological and medical health. This paper aims to summarize the recommendations of the Brazilian Association of Psychiatry - [Associação Brasileira de Psiquiatria (ABP)] for the treatment of EDs, based on the latest available evidence. Systematic reviews focused on the multidisciplinary treatment of ED were conducted. Findings were evaluated based on evidence strength, and recommendations using the evidence-based methodology of the Oxford Centre for Evidence-Based Medicine, finalized by an expert panel consensus. A summary of the recommendations and their corresponding levels of evidence was produced. Overall, the management of AN should use the least restrictive setting, combining monitored nutritional rehabilitation with psychotherapy. Pharmacotherapy plays a limited role in selected cases. BN is typically managed in an outpatient setting, focusing on structured nutritional care and CBT-based treatment, with pharmacotherapy adjunctive, preferably fluoxetine. BED is treated in an outpatient setting with structured care and CBT, with lisdexamfetamine as the preferred pharmacotherapy when needed. These guidelines represent a significant advancement in managing eating disorders in Brazil, providing a structured framework for clinical care while also supporting the development of future public mental health policies.
饮食失调(ED),如神经性厌食症(AN)、神经性贪食症(BN)和暴食症(BED),是严重的精神疾病,严重影响心理和医学健康。本文旨在总结巴西精神病学协会(associa o Brasileira de Psiquiatria, ABP)基于最新证据提出的治疗ed的建议。对ED的多学科治疗进行了系统回顾。根据证据强度和使用牛津循证医学中心循证方法的建议对调查结果进行评估,并由专家小组达成共识。提出了建议及其相应证据水平的摘要。总的来说,AN的管理应该使用限制最少的设置,将监测的营养康复与心理治疗相结合。药物治疗在选定的病例中起有限的作用。BN通常在门诊进行管理,重点是有组织的营养护理和基于cbt的治疗,辅以药物治疗,最好是氟西汀。BED在门诊接受结构化护理和CBT治疗,必要时首选利地氨苯他明。这些准则是巴西在管理饮食失调方面取得的重大进展,为临床护理提供了一个结构化框架,同时也支持制定未来的公共精神卫生政策。